Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Drug regulator meets...

    Drug regulator meets pharma sector bodies on GST and supply

    Written by Ruby Khatun Khatun Published On 2017-06-05T15:11:59+05:30  |  Updated On 5 Jun 2017 3:11 PM IST
    Drug regulator meets pharma sector bodies on GST and supply

    NEW DELHI: National drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has said it has held meetings with pharma sector associations on GST and ensured uninterrupted supply of drugs across the country.


    The regulator had earlier said it would hold meetings on June 1-2 with various industry bodies on GST and ensure supply of drugs, besides discussing other issues related to the sector.

    These bodies include Indian Drug Manufacturers Association (IDMA), Indian Pharmaceutical Alliance (IPA), Organisation of Pharmaceutical Producers of India (OPPI) and All India organisation of Chemists and Druggists (AIOCD).

    "NPPA holds fruitful discussions with industry and trade associations to ensure uninterrupted supply of drugs on implementation of GST," National Pharmaceutical Pricing Authority (NPPA) said it a tweet.

    The drug pricing regulator, however, did not elaborate on the outcome of the discussions.

    The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country.

    It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.

    The regulator implements and enforces the provisions of the Drugs (Prices Control) Order.

    The regulator is also entrusted with the task of recovering amounts overcharged by manufacturers for the controlled drugs from the consumers.
    AIOCDAll India Organisation of Chemists and DruggistsdrugsGSTIDMAIndian Drug Manufacturer's AssociationIndian Pharmaceutical AllianceIPANational Pharmaceutical Pricing AuthorityNPPAOPPIOrganisation of Pharmaceutical Producers of India
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok